Screenshot%25202020-05-27%2520at%252010_

GSK Salbutamol Programme

Project Description:

 

M2 Build is an Oral Solid Dose facility (OSD), producing tablets and capsules for the GSK brand. 

 

The project was a blend of modular design (DFMA) and traditional ‘stick built’ construction.

 

 

Key Challenges:

Providing a GMP environment

DFMA Modular Design

 

Should you wish to know more about our role on Science, Research and Healthcare projects, please contact hello@iM2ltd.com

iM2 Role: Principal Designer

Project Team:

Client: GSK

Architect: Simons Design Ltd

Engineer: Shepherd Gilmore

MEP: NG Bailey

PC: GSK

Start Date: July 2020

Completion: January 2023

Value: (£) Confidential

Screenshot 2021-09-22 at 17.28.51.png
Screenshot 2021-09-22 at 17.28.58.png
APS-logo White.jpg
iirsm_main_logo.jpg
iM2 Limited
Hamilton House
Mabledon Place
London, WC1H 9BB
England, UK
  • Twitter
  • LinkedIn

www.iM2ltd.com

0203 972 4157

CIOB-Logo.jpg
IOSH-Logo.jpg
iM2 LOGO ISSUE A OUTLINES 25-05-20.png
Screenshot%25202020-05-27%2520at%252010_